The fact that men are overrepresented in psoriasis registers and consume more psoriasis care have long led researchers to believe that the common skin disease disproportionally affects men.
Estimates suggest that 40 percent of eczema flares are treated with topical antibiotics, but findings from this study published in Annals of Family Medicine suggest there is no meaningful benefit...
The U.S. Food and Drug Administration has approved Siliq (brodalumab) to treat adults with moderate-to-severe plaque psoriasis. Siliq is administered as an injection.